Perfect Optronics Limited announced unaudited consolidated earnings guidance for the period for the nine months ended 30 September 2022. For the period, the group is expected to record a turnaround of its results from loss to profit making for the nine months ended 30 September 2022 by recording a consolidated profit attributable to equity holders of the Company within a range of approximately HKD 5 million to HKD 7 million, as compared to a consolidated loss attributable to equity holders of the Company of approximately HKD 39,676,000 for the nine months ended 30 September 2021. The abovementioned consolidated profit expected to be recorded for the Period was primarily attributable to (i) a significant increase in the profit generated from the Group's sales of health-related products (including personal hygiene and disinfectant products, rapid antigen test kits for COVID-19) during the Period as compared to the corresponding period in 2021; and (ii) the expected decrease in fair value loss on the Group's financial asset at fair value through profit or loss in respect of its investment in Mobvoi Inc. for the Period as compared to the fair value loss on the Group's financial asset at FVTPL for the corresponding period in 2021.

The positive effect of the aforementioned factors was however significantly offset by (among others) the decrease in the revenue from the sales of the Group's other major products during the Period as compared to the corresponding period in 2021.